Skip to main content

Proteomics Market is Supposed to Register a Spectacular CAGR of 14.1% During Forecast to 2023


Market Overview:
The Global Proteomics Market is rising pervasively mainly due to the proliferating trend of personalized medicines. Proteomics is used in drug discovery and clinical diagnosis for a number of applications such as the investigation of protein expression, metabolic pathways, transcriptional & post-transcriptional studies, protein interaction in diseases, etc. Moreover, the burgeoning sectors such as healthcare and pharmaceutical escalate the market on the global platform.
Analyzing the ascending graph of the growth, the market is climbing steadily, Market Research Future (MRFR), in its recently published study report confirms that the global Proteomics Market Trends will quadruple by 2023, registering a staggering double-digit CAGR over 14.1 % throughout the forecast period (2018 to 2023). In 2017, the market had accounted for a valuation of USD 23.2 BN.
Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6930
Rising advances in proteomics research and new products launched in the proteomics market is anticipated to boost the growth of the market during the assessment period. In September 2017, Bruker introduced the timsTOF Pro system for parallel accumulation and serial fragmentation (PASEF) mass spectrometry, using proprietary trapped ion mobility spectrometry (TIMS) technology for higher-speed, higher-sensitivity and robust shotgun proteomics. On the other hand, high cost of equipment & tools and lack of skilled researchers may hinder the market growth during the forecast period.
Global Proteomics Market – Competitive Analysis
The widely expanded Proteomics market appears to be highly competitive with the presence of numerous large and small-scale players. These players compete against each other based on an array of services and pricing. Naturally, the competitive strength of these players is reliant on service pricing, service precision, versatility, and reliability of services. The market is forecasted to witness fierce competition with the potential extensions in innovations. Players operating in the Proteomics market strive to offer unique services with advanced features.
Focusing on rapid expansion and integration set for 2019-2019, these service providers build a company that can offer complementary services in key regions, in the emerging market.
While acquiring a company, they ensure to acquire a company with significant professional experience, state-of-the-art capabilities, and a long history of delivering high-quality pharmaceuticals that can meet or exceed customer expectations and regulatory requirements.
Major Players:
·         Bio-Rad Laboratories
·         General Electric Company
·         Danaher
·         Siemens Ltd
·         Agilent Technologies
·         Thermo Fisher Scientific Inc
·         Genzyme Corporation
·         Bruker
·         Biognosys AG
·         Luminex Corporation
·         PerkinElmer Inc
Global
Proteomics Market – Segments
For ease of understanding, the report is segmented into four key dynamics: -

By Equipment           : Chromatography, X-ray Crystallography, Protein Fractionation, Mass Spectroscopy, and Protein Microarray among others.

By Services               : Laboratory Services, and Data Analysis & Services among others.

By Application          : Drug Discovery and Clinical Diagnosis among others.

By Regions                : North America, Asia Pacific, Europe, and the Rest-of-the-World.
Global Proteomics Market – Geographical Analysis
The global market in the Americas is segmented into two major regions, i.e., North America and South America. The North American region is likely to hold the major share in the global proteomics market owing to the rapid adoption of new technologies and investments in personalized medicines. According to a report published by the Personalized Medicine Coalition, the Food and Drug Administration approved a record number of 19 personalized medicines in 2017. It is the fourth consecutive year that personalized medicines accounted for more than 20 percent of all new drug approvals. The European region is anticipated to be the second largest due to the presence of a well-developed healthcare infrastructure and rising adoption of new technologies. The Asia-Pacific region is anticipated to be the fastest growing region due to the rising proteomics research. Middle East and Africa is anticpated to hold the least market share.

Labels:

Comments

Post a Comment

Popular posts from this blog

Covid 19 Analysis on Medical Devices and Accessories Market is Growing at a Healthy CAGR of 6.53% During Forecast to 2023

Market Insights: Medical devices and accessories refer to any apparatus, machine, instrument used for the treatment of disease and illness through monitoring, diagnosis, and treatment. Growing occurrences of chronic diseases and diabetes, geriatric population, rising cases of surgical cases, healthcare expenditure, and technological advancements for superior medical infrastructures, and constant investments by industry giants are some of the pointers that might help the global medical device and accessories market to flourish during the forecast period. Market Research Future stated that the global Covid 19 Analysis on Medical Devices and Accessories Market Growth is estimated to register a CAGR of 6.53%, reaching the valuation of USD 133,835.9 , during the forecast period, 2014-2023 . Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/5466 Other additional factors influencing the growth of the global market include mergers and collaboration led by the...
Post a Comment
Read more

BRIC Diabetes Treatment and Prevention Market is Supposed to Gain at a Fruitful CAGR of 11.52% During Forecast to 2023

Market Highlights Diabetes drugs are the drugs which are administered for the treatment of different types of Diabetes. The prevalence of diabetes is on the rise due to increased life expectancy, changing lifestyles, and the rising incidence of obesity. Diabetes can be kept in control with the help of medication, exercise and controlled diet.  Diabetes Prevention Industry in BRICS is expected to reach  USD 9.45 billion  by 2023 at a CAGR of 11.52%   during forecast period 2017 to 2023. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/1323 Test the market data and market information presented through more than 45 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Diabetes treatment and prevention market Research Report –BRICS Forecast to 2023.” BRICS diabetes treatment and prevention market players: Key players in diabetes treatment...
Post a Comment
Read more

Fluoroscopy and Mobile C-Arms Market is Substantially Gaining at a CAGR of 4.58% During Forecast to 2023

Market Overview: The increasing prevalence of chronic diseases is expected to have a significant impact on the fluoroscopy and mobile c-arms market. The market is also being encouraged by the massive geriatric population present globally. The increased pace of development in the healthcare sector is also anticipated to motivate the fluoroscopy and mobile c-arms market in the coming forecast period. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/7717 Fluoroscopy can be defined as an imaging technique, which uses X-Ray technology for taking real-time images of the body. It allows the physicians to visualize muscles, organs, and bones, which further helps them to make crucial decisions during surgery. The global Fluoroscopy And Mobile C-Arms Market Growth as per a report by Market Research Future (MRFR) is touted to register a CAGR of 4.58%, surpassing a valuation of USD 2,951.4 million during the forecast period. Competitive Dashboard: Canon Medical ...
Post a Comment
Read more